All Practice-based pharmacist articles – Page 9
-
NewsOmicron numbers continue to rise over Christmas, as the Government adopts JCVI recommendations to vaccinate vulnerable children
There are no promises from Health Secretary Sajid Javid about whether more restrictions will come in January, as latest figures show that Christmas day COVID-19 cases reached a December high
-
News
UK researchers find way to boost emerging breast cancer drug’s effectiveness
Augmenting investigational drug xentuzumab could boost oestrogen receptor-positive breast cancer cell death, according to new findings
-
News
Omicron studies suggest lower COVID-19 hospitalisation rates than Delta
Small population studies in England and Scotland suggest a reduced risk of hospitalisation from the Omicron variant of between 40 and 68%
-
NICE guideline
NICE headache guideline
This easy-to-read summary of NICE's guideline explores the diagnosis and management of tension, migraine, cluster, and medication overuse headaches
-
News
JCVI approves COVID-19 vaccine for at-risk primary school children, and boosters for some teenagers
The JCVI has recommended the rollout of low-dose COVID-19 vaccines to vulnerable 5–11 year olds, and that boosters be given to 16–17 year olds and at-risk younger teenagers
-
Independent professional body guideline
AWMSG asthma guideline
Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group
-
News
Vaccination programme expands to children aged 12–15 years for second jab, with rough sleepers also targeted
Booking for a second NHS COVID-19 vaccine opened to 12–15 year olds this week, as plans to vaccinate the homeless also get a funding boost
-
News
Dr Samantha Roberts appointed NICE Chief Executive
The new incumbent will take over from Professor Gillian Leng in February next year
-
News
Data show little improvement in patients with long COVID after 1 year
The study did, however, identify a number of modifiable factors and potential treatment targets that may improve outcomes
-
News
Artificial intelligence can aid the early prediction of incident dementia
UK researchers have developed machine learning algorithms that can predict which individuals are likely to develop dementia
-
News
Trial begins for needle-free COVID-19 vaccine
The intradermal needle-free injection system may boost vaccination uptake in individuals with a fear of needles
-
News
Outrage over dapagliflozin withdrawal for type 1 diabetes in EU
AstraZeneca said that the decision is not motivated by safety concerns, but that an increased risk of diabetic ketoacidosis may cause ‘confusion’ among clinicians using the drug to treat other indications
-
News
New data dulls enthusiasm for first COVID-19 oral treatment
Data analysis puts the efficacy of molnupiravir in reducing the risk of hospitalisation and death from COVID-19 at around 20% lower than originally believed
-
News
NICE releases its first pelvic floor dysfunction guideline, targeting women aged 12 and over
NICE has published the first guideline for prevention and non-surgical management of pelvic floor dysfunction, which emphasises the importance of raising awareness and early intervention
-
News
Omicron claims first British victim, as concerns are raised that booster expansion will disrupt NHS
Nursing leaders and patient groups have raised concerns about disruption to NHS services in the wake of the Prime Minister’s announcement of new targets for COVID-19 booster jabs
-
News
HPV vaccinations still down from pre-pandemic levels
The Government urges anyone eligible for the HPV vaccine to get vaccinated, due to concerns that the vaccine’s success in reducing cervical cancer incidence could be eroded by suboptimal uptake
-
News
Preliminary findings support the idea that the Omicron variant is more resistant to vaccines
Scientists behind Oxford’s Com-COV2 study have endorsed the importance of COVID-19 booster vaccines after finding that antibodies dip significantly following primary doses of the AstraZeneca and Pfizer jabs
-
News
Detection of serious illness in infants and young children remains a key risk in the NHS
Distinguishing between simple viral illnesses and life-threatening bacterial infections in very young patients is a key safety risk, the latest HSIB report notes
-
News
UK set for a million Omicron cases before 2022, but booster dose may give 75% protection
The UKHSA predicts that Omicron will become the dominant strain in the UK by the middle of December, accounting for more than 50% of all cases of COVID-19
-
News
Severe mental illness tied to worse COVID-19 outcomes
A Manchester University study has found higher risks of COVID-19 infection, hospitalisation, and mortality in individuals with severe mental illness
